Company Overview of Absynth Biologics Limited
Absynth Biologics Limited discovers and develops vaccines and antibodies to prevent and treat bacterial infections. It develops vaccines and therapeutic antibodies against staphylococcus aureus, clostridium difficile, and streptococcus pyogenes. The company develops products based on a platform for identifying novel protein antigen targets that harness the immune system and use a dual-action mechanism, including direct antibacterial activity by antibody-mediated inhibitory effect; and engagement of classic immune effector functions to eliminate the bacteria. Absynth Biologics Limited was founded in 2007 and is based in Alderley Edge, United Kingdom.
Alderley Edge, SK10 4TG
Founded in 2007
44 1625 238 805
Key Executives for Absynth Biologics Limited
Similar Private Companies By Industry
|Abbey Pharma Limited||Europe|
|Absynth Biologics Limited||Europe|
|Acacia Pharma Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Absynth Biologics Limited, please visit www.absynthbiologics.co.uk. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.